The knockdown of CXCL9 leads to the decreased expressions of Bax/Bcl-2 and inactivation of the Janus kinase 2 (JAK2)/STAT3 pathway, resulting in anti-apoptotic and anti-inflammatory effects in a model of mouse podocyte injury of DM [81]. The gene discussed is JAK2; the disease is diabetes mellitus.